🔎 Trials Near Me

Akèy › Trigliserid

Etid klinik pou Trigliserid ap rekrite nan Etazini

9 etid pou Trigliserid ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07269210

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT06880770

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Sep 18, 2026 · NCT07491172

A Study to Assess the Safety, Tolerability and Efficacy of ION775

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07604974

Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07028749

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06822790

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Jul 17, 2026 · NCT06451770

A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Nov 6, 2025 · NCT07199309

Differential Thrombogenesis by EPA and DHA Mediated by HDL

Ap rekriteFaz 1 bonè
Laj 18 a 69 · Tout sèks · Mizajou Oct 1, 2025 · NCT06494488

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.